#NewAseBioMember | “AseBio is a key meeting point for companies and entities driving biotechnology in Spain”

AseBio. What does your company's work bring to the table and what is its strength?

Cristina Moreno. At Biomol, our mission is to accelerate access to precision medicine and molecular biology solutions for professionals. We specialize in the distribution of innovative equipment and reagents, ensuring that hospitals, research centers, and biotech companies in Spain and Portugal have access to cutting-edge tools.

Our strength lies in our deep knowledge of the sector, our ability to adapt to market needs, and a consultative approachthat goes beyond simple distribution: we provide specialized technical advice, training, and tailored solutions for each client.

We are increasingly positioning ourselves as a strategic partner for biotech companies looking for access to high-end technology and expert support in the implementation of their projects.

AseBio. What is AseBio for you?

Cristina Moreno. For Biomol, AseBio is a key meeting point for companies and entities driving biotechnology in Spain. We believe that collaboration and networking within our ecosystem are essential to advancing innovation and creating real impact in the sector.

AseBio represents a platform for visibility and growth, allowing us to connect with other companies and entities to develop strategic projects in diagnostics, translational research, and applied biotechnology.

AseBio. When did you first hear about AseBio?

Cristina Moreno. We have been closely following AseBio’s work for years and its role in the development of the biotechnology sector in Spain.

As Biomol expanded its focus towards collaboration with hospitals, biotech companies, and research centers, it became a natural step to join this community, fostering synergies and strengthening our positioning.

AseBio. What do you expect from being part of an association like AseBio?

Cristina Moreno. We aim to strengthen our presence in the sector and actively contribute with our knowledge and expertise in accessing advanced technologies for molecular and cellular biology.

Additionally, we seek to:

• Connect with biotech companies and startups that need a technology partner to scale their projects.
• Access collaboration and business development opportunities, both nationally and internationally.
• Participate in key forums and events, where we can share our vision for the future of molecular diagnostics, genomics, translational research, and ultimately, the advancement of life sciences.
• Contribute our expertise in the implementation of cutting-edge technologies, driving progress in the sector.

AseBio. What is the biggest challenge facing the biotech sector or your company?

Cristina Moreno. Our sector faces multiple challenges, but from our perspective, the most relevant are:

• Ensuring seamless access to technology and innovation → Making sure that advances in personalized medicineand molecular biology reach hospitals and laboratories quickly and efficiently.
• Digital transformation and automation in laboratories → The adoption of technologies such as artificial intelligence, biomedical data analysis, and process automation is key to improving efficiency and reducing costs.
• Regulation and market access → Supporting companies in the complex process of validating and certifying new technologies, while also exploring different solutions in our own production line.
• Encouraging investment and public-private collaboration → Driving innovation requires a strong ecosystemthat facilitates funding, access to infrastructure, and cooperation among key players.

At Biomol, we are working to become a strategic partner that helps overcome these challenges, providing access to innovative solutions and specialized technical support, not only as a distributor but also as a manufacturer.